Literature DB >> 14642500

MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM).

Michael Hutchinson1, Ulrich Raff, Sergey Lebedev.   

Abstract

The two commonest, clinically well-defined, forms of parkinsonism are idiopathic Parkinson's disease (PD) and progressive supranuclear palsy (PSP). Both involve, inter alia, pathological changes in the substantia nigra pars compacta (SN(C)). In PD there is neuronal loss with associated Lewy body pathology and microglial activation. Three morphological features have been identified [Brain 114 (1991), 2283; Greenfield's Neuropathology 2 (1997), 289]. First, there is a gradient of pathological change such that the lateral segments are more affected than the medial. Second, there is thinning of the pigmented tissue, and third, there is a broadening of the overall structure in a dorsal-ventral direction, possibly caused by the migration of melanin-laden macrophages [Greenfield's Neuropathology 2 (1997), 289]. In contrast, PSP is characterized pathologically by intraneuronal neurofibrillary tangles. There are two morphological features in the SN(C) [Brain 114 (1991), 2283]. First, the gradient of pathological change is in the opposite direction to that of PD (i.e., the medial segments are more affected than the lateral). Second, there is atrophy. Any technique sensitive to neuropathology should be capable of detecting these features. We have previously reported on a new approach to detecting signal change in the substantia nigra in PD. This makes use of a ratio of images acquired by two distinct inversion recovery sequences [J. Neurol, Neurosurg. Psychiatry 67 (1999), 815; Am. J. Neuroradiol. 21 (2000) 697]. The prior work suggests that the technique is sensitive to, but not necessarily specific for, PD. We present here a preliminary report on an extension of the work. This is a semiautomated segmentation analysis that enables the substantia nigra to be displayed as an isolated structure. The technique is now given the acronym SIRRIM (segmented inversion recovery ratio imaging). In contrast to our earlier work, it allows for a more accurate assessment of the gross abnormalities. We report typical SIRRIM images of the SN(C). Images are shown for three subjects: a normal control, a patient with PD, and a "disease control" (a patient with PSP). In these examples all three morphological features of PD, as well as both morphological features of PSP, have radiological correlates. These preliminary findings suggest that SIRRIM may be specific for both diseases.

Entities:  

Mesh:

Year:  2003        PMID: 14642500     DOI: 10.1016/j.neuroimage.2003.07.012

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  12 in total

Review 1.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.

Authors:  Graziella Donatelli; Roberto Ceravolo; Daniela Frosini; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-20       Impact factor: 5.081

3.  Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.

Authors:  M Cosottini; D Frosini; I Pesaresi; G Donatelli; P Cecchi; M Costagli; L Biagi; R Ceravolo; U Bonuccelli; M Tosetti
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-06       Impact factor: 3.825

Review 4.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

5.  Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging.

Authors:  L Minati; M Grisoli; F Carella; T De Simone; M G Bruzzone; M Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

6.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

7.  Harnessing advances in structural MRI to enhance research on Parkinson's disease.

Authors:  David A Ziegler; Jean C Augustinack
Journal:  Imaging Med       Date:  2013-04

Review 8.  A review of the use of magnetic resonance imaging in Parkinson's disease.

Authors:  Nadya Pyatigorskaya; Cécile Gallea; Daniel Garcia-Lorenzo; Marie Vidailhet; Stéphane Lehericy
Journal:  Ther Adv Neurol Disord       Date:  2014-07       Impact factor: 6.570

9.  Spin-lattice distribution MRI maps nigral pathology in progressive supranuclear palsy (PSP) during life: a pilot study.

Authors:  Michael Hutchinson; Ulrich Raff; Pedro Chaná; Isidro Huete
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

10.  9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.

Authors:  L A Massey; M A Miranda; O Al-Helli; H G Parkes; J S Thornton; P-W So; M J White; L Mancini; C Strand; J Holton; A J Lees; T Revesz; T A Yousry
Journal:  Neuroimage Clin       Date:  2016-11-17       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.